The causes and treatment outcomes of 91 patients with adult nosocomial meningitis

Korean Journal of Internal Medicine

Volumn 27, Issue 2, 2012, Pages 171-179

  Kim, Hye In ^a   Kim, Shin Woo ^a   Park, Ga Young ^a   Kwon, Eu Gene ^a   Kim, Hyo Hoon ^a   Jeong, Ju Young ^a   Chang, Hyun Ha ^a   Lee, Jong Myung ^a   Kim, Neung Su ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Acinetobacter; Drug resistance; Meningitis; Prognosis

Indexed keywords

AMIKACIN; AMPHOTERICIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFMINOX; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; FORTIMICIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MINOCYCLINE; MONOBACTAM; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULTAMICILLIN; TEICOPLANIN; TIMENTIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ACINETOBACTER LWOFFII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM CULTURE; CAUSAL ATTRIBUTION; CAUSE OF DEATH; CEREBROSPINAL FLUID CULTURE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EFFECT; FEMALE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION ERROR; PROGNOSIS; SEPTIC SHOCK; SURVIVAL RATE; TREATMENT OUTCOME;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEREBROSPINAL FLUID; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862880332     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2012.27.2.171     Document Type: Article

References (26)

1. van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med 2010;362:146-154.
2. Streharova A, Benca J, Holeckova K, et al. Comparison of postsurgical and community acquired bacterial meningitis: analysis of 372 cases within a nationwide survey. Neuro Endocrinol Lett 2007;28 Suppl 3:7-9.
3. Weisfelt M, van de Beek D, Spanjaard L, de Gans J. Nosocomial bacterial meningitis in adults: a prospective series of 50 cases. J Hosp Infect 2007;66:71-78.
4. Ross D, Rosegay H, Pons V. Differentiation of aseptic and bacterial meningitis in postoperative neurosurgical patients. J Neurosurg 1988;69:669-674.
5. Wang KW, Chang WN, Huang CR, et al. Post-neurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes. J Clin Neurosci 2005;12:647-650.
6. Benca J, Ondrusova A, Kisac P, Krcmery V. Postoperative meningitis: shift in etiology? Neuro Endocrinol Lett 2007;28 Suppl 3:22.
7. Pintado V, Meseguer MA, Fortun J, et al. Clinical study of 44 cases of Staphylococcus aureus meningitis. Eur J Clin Microbiol Infect Dis 2002;21:864-868.
8. Hodges GR, Perkins RL. Hospital-associated bacterial meningitis. Am J Med Sci 1976;271:335-341.
9. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-1284.
10. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med 1993;328:21-28.
11. O'Neill E, Humphreys H, Phillips J, Smyth EG. Third-generation cephalosporin resistance among Gram-negative bacilli causing meningitis in neurosurgical patients: significant challenges in ensuring effective antibiotic therapy. J Antimicrob Chemother 2006;57:356-359.
12. Erdem I, Hakan T, Ceran N, et al. Clinical features, laboratory data, management and the risk factors that affect the mortality in patients with postoperative meningitis. Neurol India 2008;56:433-437.
13. Rodriguez Guardado A, Blanco A, Asensi V, et al. Multidrugresistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 2008;61:908-913.
14. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the cute care setting. Am J Infect Control 2008;36:309-332.
15. Yoo JH. Infectious complications after neurosurgery: mainly focusing on ventriculitis and meningitis. Infect Chemother 2011;43:229-233.
16. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63-78.
17. Wen DY, Bottini AG, Hall WA, Haines SJ. Infections in neurologic surgery: the intraventricular use of antibiotics. Neurosurg Clin N Am 1992;3:343-354.
18. Kim BN, Peleg AY, Lodise TP, et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 2009;9:245-255.
19. Beer R, Lackner P, Pfausler B, Schmutzhard E. Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol 2008;255:1617-1624.
20. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;29 Suppl A:19-24.
21. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274:639-644.
22. Gantz NM. Nosocomial central nervous system infections. In: Mayhall CG, ed. Hospital epidemiology and infection control. 2nd ed. Philadelphia: Lippincott Williams and Wilkins, 1999:301-322.
23. Palabiyikoglu I, Tekeli E, Cokca F, et al. Nosocomial meningitis in a university hospital between 1993 and 2002. J Hosp Infect 2006;62:94-97.
24. Katragkou A, Roilides E. Successful treatment of multidrugresistant Acinetobacter baumannii central nervous system infections with colistin. J Clin Microbiol 2005;43:4916-4917.
25. Gales AC, Jones RN, Sader HS. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect 2006;12:315-321.
26. Falagas ME, Bliziotis IA, Tam VH. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 2007;29:9-25.